Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

235.08 +3.35 (+1.45%)
Streaming Delayed Price Updated: 9:35 AM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 269,943
Open 233.08
Bid (Size) 235.08 (200)
Ask (Size) 235.29 (100)
Prev. Close 231.73
Today's Range 232.72 - 235.33
52wk Range 149.04 - 251.71
Shares Outstanding 2,628,679,824
Dividend Yield 2.21%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets ↗
ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget. 
Via The Motley Fool
Topics ETFs Energy
News headline image
3 Dividend Kings to Buy and Hold for 20 Years ↗
When it comes to reliable dividend payouts, these three companies keep rewarding their long-term shareholders. 
Via The Motley Fool
Topics Retirement

Performance

YTD
+13.4%
+13.4%
1 Month
+3.9%
+3.9%
3 Month
-4.8%
-4.8%
6 Month
+15.8%
+15.8%
1 Year
+53.5%
+53.5%

More News

Read More
News headline image
Meet the Dividend King With a Higher Credit Rating Than the U.S. Government ↗
Via The Motley Fool
Topics Economy
Johnson & Johnson (NYSE:JNJ) Screens Well as a Dependable Dividend Aristocrat ↗
Via Chartmill
News headline image
3 Dividend Stocks Warren Buffett Would Buy in a Market Crash ↗
Via The Motley Fool
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
Via Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery
Via Investor Brand Network
Topics Intellectual Property
News headline image
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
From BioMedWire
Via GlobeNewswire
News headline image
Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
From Johnson & Johnson
Via Business Wire
News headline image
Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors. ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Income or Growth: Which Healthcare Stock Fits Your Portfolio Right Now? ↗
Via The Motley Fool
Topics Economy Retirement Stocks
News headline image
2 Dividend Stocks That Are No-Brainer Buys in May ↗
Via The Motley Fool
Topics Economy
News headline image
These Market Signals Alarm Me, but I Still See Profit Potential in These 3 Consumer Stocks ↗
Via The Motley Fool
News headline image
3 Unstoppable Dividend King Stocks to Buy Right Now for Less Than $550 ↗
Via The Motley Fool
News headline image
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Is Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy? ↗
Via The Motley Fool
News headline image
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
From Johnson & Johnson
Via Business Wire
News headline image
Are Wall Street Analysts Bullish on Johnson & Johnson Stock?
Via Barchart.com
Topics ETFs
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
Via The Motley Fool
News headline image
Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying? ↗
Via The Motley Fool
Topics World Trade
News headline image
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
From Johnson & Johnson
Via Business Wire
News headline image
Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering ↗
Via The Motley Fool
News headline image
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
From Johnson & Johnson
Via Business Wire
News headline image
Is Bristol Myers Squibb the Best Bargain in Big Pharma? ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 235.08
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 05/22/26 09:35 AM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 617.95B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 618B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.